You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ellipsoid zone

Showing 1 - 25 of 787
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation

Not yet recruiting
  • Autosomal Dominant Optic Atrophy
  • +3 more
    • Sydney, Australia
      Sydney Eye Hospital
    Nov 15, 2023

    Retinitis Pigmentosa Trial in Durham (ADX-2191)

    Recruiting
    • Retinitis Pigmentosa
    • Durham, North Carolina
      Duke Eye Center
    Sep 26, 2022

    Retinitis Pigmentosa Trial in Ankara (Wharton's jelly derived mesenchymal stemcells, Magnovision)

    Completed
    • Retinitis Pigmentosa
    • Wharton's jelly derived mesenchymal stemcells
    • Magnovision
    • Ankara, Gölbaşı, Turkey
    • +2 more
    Mar 23, 2023

    Retinal Dystrophy, PRPF31 Mutationassociated Retinal Dystrophy, RP11 Trial in Dallas (VP-001)

    Recruiting
    • Retinal Dystrophy
    • +2 more
    • Dallas, Texas
      Retina Foundation of the Southwest
    Jun 5, 2023

    Foveal Sparing ILM Peeling With ILM Flap Transposition

    Completed
    • Full Thickness Macular Hole
    • retrospective data analysis
    • Vienna, Austria
      Hanusch Hospital, Department of Ophthalmology
    Jun 10, 2023

    Macular Telangiectasia Trial in Milwaukee (577-nm PASCAL laser)

    Active, not recruiting
    • Macular Telangiectasia
    • 577-nm PASCAL laser
    • Milwaukee, Wisconsin
      Medical College of Wisconsin & Froedtert Hospital
    Dec 27, 2022

    Macular Telangiectasia Trial in Australia, United States (Ciliary neurotrophic factor (CNTF), Surgery)

    Completed
    • Macular Telangiectasia
    • Ciliary neurotrophic factor (CNTF)
    • Surgery
    • Los Angeles, California
    • +10 more
    Mar 15, 2022

    Retinitis Pigmentosa Trial (2C-QD, Sham 2C-QD)

    Not yet recruiting
    • Retinitis Pigmentosa
    • 2C-QD
    • (no location specified)
    Apr 24, 2023

    A Collaborative Resource of Heidelberg Multimodal Imaging of

    Not yet recruiting
    • Age Related Macular Degeneration
    • +3 more
    • Collection of both retrospective and prospective data collection in 3 visits.
    • (no location specified)
    Jan 16, 2023

    Diabetic Retinopathy Trial in Coimbra

    Recruiting
    • Diabetic Retinopathy
      • Coimbra, Portugal
        AIBILI - Association for Innovation and Biomedical Research on L
      Aug 1, 2022

      Evaluate Functional and Anatomical Progression in Retinitis

      Recruiting
      • Retinitis Pigmentosa
        • Baltimore, Maryland
          Wilmer Eye Institute at Johns Hopkins University
        Sep 15, 2022

        Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

        Recruiting
        • Retinitis Pigmentosa
        • +4 more
          • San Francisco, California
          • +4 more
          Oct 5, 2022

          Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)

          Recruiting
          • Retinitis Pigmentosa
          • +7 more
          • San Diego, California
          • +14 more
          Jul 29, 2022

          Retinitis Pigmentosa, Usher Syndrome Type 2 Trial in Canada, France, United States (RNA antisense oligonucleotide for

          Terminated
          Has Results
          • Retinitis Pigmentosa
          • Usher Syndrome Type 2
          • RNA antisense oligonucleotide for intravitreal injection
          • Boston, Massachusetts
          • +6 more
          Dec 12, 2022

          Stargardt Disease 1 Trial in Worldwide (Zimura, Sham)

          Recruiting
          • Stargardt Disease 1
          • Phoenix, Arizona
          • +41 more
          Sep 7, 2022

          Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis Trial in Worldwide (sepofarsen, Sham)

          Active, not recruiting
          • Leber Congenital Amaurosis 10
          • +9 more
          • Iowa City, Iowa
          • +13 more
          Mar 2, 2022

          Retinitis Pigmentosa Trial in Worldwide (N-acetylcysteine, Placebo)

          Not yet recruiting
          • Retinitis Pigmentosa
          • Davis, California
          • +30 more
          Sep 8, 2022

          Retinitis Pigmentosa Trial in Baltimore (N-Acetyl Cysteine (NAC))

          Completed
          • Retinitis Pigmentosa
          • N-Acetyl Cysteine (NAC)
          • Baltimore, Maryland
            Wilmer Eye Institute, Johns Hopkins
          Sep 15, 2022

          AMD, Soft Drusen, Reticular Pseudodrusen Trial in Barcelona (Postbotics and Vitamins, Vitamins)

          Recruiting
          • AMD
          • +4 more
          • Postbotics and Vitamins
          • Vitamins
          • Barcelona, Spain
            Institut de la Macula
          Sep 14, 2021

          Diabetic Macular Edema Trial in Houston (Dexamethasone implant, Aflibercept)

          Recruiting
          • Diabetic Macular Edema
          • Houston, Texas
            Retina Consultants of Houston
          Jul 19, 2021

          Macular Telangiectasia Type 2 Trial in Worldwide (NT-501, Sham)

          Active, not recruiting
          • Macular Telangiectasia Type 2
          • NT-501
          • Sham
          • La Jolla, California
          • +21 more
          Mar 15, 2022

          Vitreomacular Traction Trial in United States (Pneumatic Vitreolysis (C3F8 injection), Observation)

          Completed
          Has Results
          • Vitreomacular Traction
          • Pneumatic Vitreolysis (C3F8 injection)
          • Observation
          • Campbell, California
          • +40 more
          Sep 6, 2022

          Macular Telangiectasia Type 2 Trial in Australia, Germany, United States (NT-501, Sham)

          Active, not recruiting
          • Macular Telangiectasia Type 2
          • NT-501
          • Sham
          • Beverly Hills, California
          • +26 more
          Mar 15, 2022

          Separation Sign: New Ultrasound Sign to Rule Out Placenta

          Not yet recruiting
          • Accreta, Placenta
          • Separation sign
          • Banī Suwayf, Beni Suef, Egypt
            Beni-suef university Hospital
          Aug 1, 2023

          Stargardt Disease Trial in Worldwide (Emixustat, Placebo)

          Completed
          • Stargardt Disease
          • Beverly Hills, California
          • +28 more
          Jun 30, 2022